Serial Number:
97826078
Mark:
BOMYNTRA
Status:
Registered
Status Date:
12-19-2023
Filing Date:
Registration Number:
7249314
Registration Date:
12-19-2023
Pharmaceutical preparations for human use for the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for human use for the prevention of fractures; pharmaceutical preparations for human use for prevention of pain associated with oncological and metabolic diseases and disorders; pharmaceutical preparations for human use for surgery, namely, for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors; pharmaceutical preparations for human use for radiotherapy, namely, for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors; pharmaceutical preparations for human use for the treatment and prevention of bone metastases, solid tumors, osteolytic bone lesions of multiple myeloma, hypercalcemia of malignancy, giant cell tumor of bone
Mark Description:
N/A
Class:
Pharmaceutical and veterinary preparations
Type of Mark:
Trademark
Published for Opposition Date:
10-03-2023
Mark Drawing Status:
Standart Character Mark
Abandon Date:
N/A
Business Name:
SMITH, GAMBRELL & RUSSELL, LLP
Correspondent Name:
